Your browser doesn't support javascript.
loading
Cancer stem cell drugs target K-ras signaling in a stemness context.
Najumudeen, A K; Jaiswal, A; Lectez, B; Oetken-Lindholm, C; Guzmán, C; Siljamäki, E; Posada, I M D; Lacey, E; Aittokallio, T; Abankwa, D.
Afiliação
  • Najumudeen AK; Turku Centre for Biotechnology, Åbo Akademi University, Turku, Finland.
  • Jaiswal A; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
  • Lectez B; Turku Centre for Biotechnology, Åbo Akademi University, Turku, Finland.
  • Oetken-Lindholm C; Turku Centre for Biotechnology, Åbo Akademi University, Turku, Finland.
  • Guzmán C; Turku Centre for Biotechnology, Åbo Akademi University, Turku, Finland.
  • Siljamäki E; Turku Centre for Biotechnology, Åbo Akademi University, Turku, Finland.
  • Posada IM; Turku Centre for Biotechnology, Åbo Akademi University, Turku, Finland.
  • Lacey E; Microbial Screening Technologies Pty. Ltd., Building C, Smithfield, New South Wales, Australia.
  • Aittokallio T; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
  • Abankwa D; Turku Centre for Biotechnology, Åbo Akademi University, Turku, Finland.
Oncogene ; 35(40): 5248-5262, 2016 10 06.
Article em En | MEDLINE | ID: mdl-26973241

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Proteínas Proto-Oncogênicas p21(ras) / Sesterterpenos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncogene Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Proteínas Proto-Oncogênicas p21(ras) / Sesterterpenos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncogene Ano de publicação: 2016 Tipo de documento: Article